|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
O-(chloroacetylcarbamoyl)fumagillol results in increased expression of CCND1 protein |
CTD |
PMID:15276080 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
O-(chloroacetylcarbamoyl)fumagillol results in increased expression of CDKN1A protein |
CTD |
PMID:15276080 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions decreases expression |
ISO |
[O-(chloroacetylcarbamoyl)fumagillol co-treated with docetaxel] results in decreased expression of FGF2 protein O-(chloroacetylcarbamoyl)fumagillol results in decreased expression of FGF2 protein |
CTD |
PMID:12576464 |
|
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
[O-(chloroacetylcarbamoyl)fumagillol co-treated with docetaxel] results in decreased expression of MMP9 protein |
CTD |
PMID:12576464 |
|
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
O-(chloroacetylcarbamoyl)fumagillol inhibits the reaction [Diethylnitrosamine results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:16061884 |
|
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
O-(chloroacetylcarbamoyl)fumagillol inhibits the reaction [Diethylnitrosamine results in increased activity of NOS2 protein] |
CTD |
PMID:16061884 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
O-(chloroacetylcarbamoyl)fumagillol results in decreased phosphorylation of RB1 protein |
CTD |
PMID:15276080 |
|
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
O-(chloroacetylcarbamoyl)fumagillol inhibits the reaction [Diethylnitrosamine results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:16061884 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
O-(chloroacetylcarbamoyl)fumagillol inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of and results in increased activity of SOD2 protein] |
CTD |
PMID:17761372 |
|
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
O-(chloroacetylcarbamoyl)fumagillol results in increased expression of TP53 protein |
CTD |
PMID:15276080 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Bco1 |
beta-carotene oxygenase 1 |
increases expression |
ISO |
Ro 41-5253 results in increased expression of BCO1 mRNA; Ro 41-5253 results in increased expression of BCO1 protein |
CTD |
PMID:16186334 |
|
NCBI chr19:49,637,059...49,673,577
Ensembl chr19:49,637,016...49,673,808
|
|
G |
Ccnd3 |
cyclin D3 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [CPG-oligonucleotide results in increased expression of CCND3 protein]] |
CTD |
PMID:17209053 |
|
NCBI chr 9:15,404,816...15,410,905
Ensembl chr 9:15,404,822...15,410,943
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNE1 protein]] |
CTD |
PMID:12421932 |
|
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Cd1d1 |
CD1d1 molecule |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of CD1D mRNA]; Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of CD1D mRNA] |
CTD |
PMID:17392484 |
|
NCBI chr 2:186,330,298...186,333,805
Ensembl chr 2:186,330,298...186,333,805
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]] |
CTD |
PMID:12421932 |
|
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid results in increased expression of CYP26A1 mRNA]; Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of CYP26A1 mRNA] |
CTD |
PMID:10953040 |
|
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
ISO |
Ro 41-5253 results in increased expression of FABP4 mRNA |
CTD |
PMID:17290005 |
|
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions |
EXP |
Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of FTH1 mRNA] |
CTD |
PMID:22154532 |
|
NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased expression of GJA1 protein]; Ro 41-5253 inhibits the reaction [beta Carotene results in increased expression of GJA1 protein] |
CTD |
PMID:16091010 |
|
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [IFNG protein promotes the reaction [Tretinoin results in increased expression of MUC4 protein]]; Ro 41-5253 inhibits the reaction [IFNG protein results in increased expression of MUC4 protein]; Ro 41-5253 inhibits the reaction [Tretinoin results in decreased secretion of IFNG protein] |
CTD |
PMID:16007204 PMID:16872382 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of IFNGR1 protein] |
CTD |
PMID:16085646 |
|
NCBI chr 1:15,062,380...15,080,815
Ensembl chr 1:15,062,432...15,080,907
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin results in increased secretion of IL10 protein] |
CTD |
PMID:16872382 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin results in decreased secretion of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:16872382 |
|
NCBI chr 2:165,076,945...165,083,996
Ensembl chr 2:165,076,607...165,084,318
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin results in decreased secretion of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:16872382 |
|
NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin results in increased secretion of IL4 protein] |
CTD |
PMID:16872382 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
[Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein |
CTD |
PMID:17290005 |
|
NCBI chr 1:215,856,967...215,858,034
Ensembl chr 1:215,856,971...215,858,034
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
multiple interactions |
EXP |
Ro 41-5253 inhibits the reaction [Tretinoin results in decreased expression of IREB2 mRNA] |
CTD |
PMID:22154532 |
|
NCBI chr 8:59,450,974...59,503,634
Ensembl chr 8:59,420,123...59,501,118
|
|
G |
Irf1 |
interferon regulatory factor 1 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of IRF1 protein]; Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of IRF1 protein] |
CTD |
PMID:16085646 PMID:16636311 |
|
NCBI chr10:39,109,530...39,116,532
Ensembl chr10:39,109,522...39,116,531
|
|
G |
Muc4 |
mucin 4, cell surface associated |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [IFNG protein promotes the reaction [Tretinoin results in increased expression of MUC4 protein]]; Ro 41-5253 inhibits the reaction [IFNG protein results in increased expression of MUC4 protein]; Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of MUC4 protein] |
CTD |
PMID:16007204 |
|
NCBI chr11:71,242,973...71,285,217
Ensembl chr11:71,243,334...71,284,939
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]]; Ro 41-5253 inhibits the reaction [tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] |
CTD |
PMID:17291456 |
|
NCBI chr18:77,203,517...77,322,690
Ensembl chr18:77,203,525...77,322,690
|
|
G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of OAS2 mRNA]; Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of OAS2 mRNA] |
CTD |
PMID:16636311 |
|
NCBI chr12:41,341,417...41,363,124
Ensembl chr12:41,340,815...41,363,161
|
|
G |
Plat |
plasminogen activator, tissue type |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Retinoids results in increased expression of PLAT] |
CTD |
PMID:7556191 |
|
NCBI chr16:74,098,263...74,122,897
Ensembl chr16:74,098,260...74,122,889
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
affects binding multiple interactions |
ISO |
Ro 41-5253 binds to PPARD protein Ro 41-5253 inhibits the reaction [GW 2433 binds to PPARD protein] |
CTD |
PMID:17290005 |
|
NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
[Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein; Ro 41-5253 binds to and results in increased activity of PPARG protein; Ro 41-5253 inhibits the reaction [pioglitazone results in increased activity of PPARG protein]; Ro 41-5253 inhibits the reaction [rosiglitazone binds to PPARG protein] [Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein; Ro 41-5253 results in increased activity of and results in decreased expression of PPARG protein |
CTD |
PMID:17290005 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Rara |
retinoic acid receptor, alpha |
multiple interactions decreases activity increases response to substance |
ISO |
Am 580 inhibits the reaction [Ro 41-5253 results in decreased activity of RARA protein]; Ro 41-5253 binds to and results in decreased activity of RARA protein; Ro 41-5253 inhibits the reaction [[RARA protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA]; Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of RARA mRNA] RARA protein results in increased susceptibility to Ro 41-5253 |
CTD |
PMID:7556191 PMID:8838863 PMID:10779427 PMID:17216566 PMID:17290005 PMID:25550158 |
|
NCBI chr10:86,838,819...86,884,224
Ensembl chr10:86,860,685...86,884,210
|
|
G |
Rarb |
retinoic acid receptor, beta |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [[RARB protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA] |
CTD |
PMID:25550158 |
|
NCBI chr15:9,915,223...10,262,599
Ensembl chr15:10,120,206...10,262,599
|
|
G |
Rarg |
retinoic acid receptor, gamma |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [[RARG protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA] |
CTD |
PMID:25550158 |
|
NCBI chr 7:143,840,739...143,863,206
Ensembl chr 7:143,839,980...143,863,186
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RB1 protein]] |
CTD |
PMID:12421932 |
|
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [[RARA protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA]; Ro 41-5253 inhibits the reaction [[RARB protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA]; Ro 41-5253 inhibits the reaction [[RARG protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA] |
CTD |
PMID:25550158 |
|
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
multiple interactions increases response to substance decreases expression |
ISO |
Ro 41-5253 inhibits the reaction [[RARA protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA]; Ro 41-5253 inhibits the reaction [[RARB protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA]; Ro 41-5253 inhibits the reaction [[RARG protein co-treated with RXRA protein] results in increased expression of SLC10A1 mRNA] SLC10A1 protein results in increased susceptibility to Ro 41-5253 Ro 41-5253 results in decreased expression of SLC10A1 mRNA; Ro 41-5253 results in decreased expression of SLC10A1 protein |
CTD |
PMID:25550158 |
|
NCBI chr 6:104,617,730...104,631,355
Ensembl chr 6:104,617,730...104,631,355
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions decreases expression |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased phosphorylation of and results in increased activity of STAT1 protein]; Ro 41-5253 inhibits the reaction [Tretinoin results in increased phosphorylation of and results in increased activity of STAT1 protein] Ro 41-5253 results in decreased expression of STAT1 protein |
CTD |
PMID:16007204 PMID:16085646 |
|
NCBI chr 9:54,287,540...54,327,958
Ensembl chr 9:54,287,541...54,484,533
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
EXP |
Ro 41-5253 inhibits the reaction [Tretinoin results in decreased expression of TFRC mRNA] |
CTD |
PMID:22154532 |
|
NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
Ro 41-5253 inhibits the reaction [Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]]; Ro 41-5253 inhibits the reaction [tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] |
CTD |
PMID:17291456 |
|
NCBI chr15:60,482,527...60,512,704
Ensembl chr15:60,482,527...60,512,704
|
|